期刊文献+

同型半胱氨酸和超敏C反应蛋白在下肢深静脉血栓诊断中的应用

Application of Homocysteine and High-sensitivity C-reactive Protein in the Diagnosis of Deep Venous Thrombosis of Lower Extremities
下载PDF
导出
摘要 目的研究与分析同型半胱氨酸和超敏C反应蛋白在下肢深静脉血栓诊断中的应用价值。方法选取该院2017年8月-2018年12月收治下肢骨折疾病患者82例,根据患者术后是否出现下肢深静脉血栓的情况进行分组,其中43例出现下肢深静脉血栓疾病的患者作为研究组,39例未出现下肢深静脉血栓疾病的患者作为对照组,分别在术后1d,2d以及3d对两组研究者采用胶乳增强免疫比浊法来检测患者的同型半胱氨酸和超敏C反应蛋白等指标,同时观察两组患者的相关凝血功能指标。结果研究组与对照组患者术后2 d,3 d的同型半胱氨酸和超敏C反应蛋白等指标差异显著,研究组患者的各项指标均较高(17.1±1.9)mol/L,(16.4±1.6)mol/L,(38.5±3.8)mg/L,(35.5±3.3)mg/L vs (9.3±1.4)mol/L,(8.9±1.4)mol/L,(15.5±1.5)mg/L,(19.3±1.9)mg/L,差异有统计学意义(t=21.672 1,23.132 7,35.158 6,26.568 2,P<0.05)。研究组与对照组患者术后1 d的凝血酶原时间以及活化部分凝血活酶时间等指标差异无统计学意义(t=0.395 4,P>0.05)。而研究组与对照组患者术后2d,3d的凝血酶原时间以及活化部分凝血活酶时间等指标差异显著,研究组患者的各项指标均较高(16.7±1.2)s,(46.3±2.3)s,(16.2±1.0)s,(44.8±2.5)s vs (13.8±1.3)s,(38.3±1.9)s,(13.8±1.4)s,(38.3±1.9)s,差异有统计学意义(t=10.504 4,17.069 9,8.994 8,13.151 1,P<0.05)。结论同型半胱氨酸和超敏C反应蛋白在下肢深静脉血栓诊断中的应用价值较高,可以在临床上加以推广与使用。 Objective To study and analyze the value of homocysteine and high-sensitivity C-reactive protein in the diagnosis of deep venous thrombosis of lower extremities. Methods A total of 82 patients with lower extremity fractures were enrolled from August 2017 to December 2018 in our hospital. According to whether there were deep venous thrombosis in the lower limbs, 43 patients with deep venous thrombosis of the lower extremities were studied. In the control group, 39 patients with no deep venous thrombosis of the lower extremities were used as the control group. The mice were tested for homocysteine and hypersensitivity by latex-enhanced immuno-turbidimetry at 1 day, 2 days and 3 days after surgery. C-reactive protein and other indicators, while observing the relevant coagula-tion function indicators in the two groups of patients. Results There were significant differences in the expression of homocysteine and high-sensitivity C-reactive protein between the study group and the control group at 2 and 3 days after operation. The indexes of the study group were higher(17.1 ±1.9)mol/L,(16.4±1.6)mol/L,(38.5 ±3.8)mg/L,(35.5 ±3.3)mg/L vs(9.3 ±1.4)mol/L,(8.9 ±1.4)mol/L,(15.5±1.5)mg/L,(19.3±1.9)mg/L. The difference was statistically significant(t=21.672 1, 23.132 7, 35.158 6, 26.568 2, P<0.05).There was no significant difference in the prothrombin time and activated partial thromboplastin time between the study group and the control group at 1 day after surgery, and the difference was not statistically significant(t=0.395 4, P>0.05). The indexes of prothrombin time and activated partial thromboplastin time were significantly different between the study group and the control group at 2 days and 3 days after operation. The indexes of the study group were higher(16.7 ±1.2)s,(46.3±2.3)s,(16.2±1.0)s,(44.8±2.5)s vs(13.8±1.3)s,(38.3±1.9)s,(13.8±1.4)s,(38.3±1.9)s, the difference was statistically significant(t=10.504 4, 17.069 9, 8.994 8, 13.1511, P<0.05). Conclusion The use of homocysteine and high-sensitivity C-reactive protein in the diagnosis of deep venous thrombosis of lower extremity is high and can be promoted and used clinically.
作者 陈晶莹 王韫光 王丽静 黄永存 CHEN Jing-ying;WANG Yun-guang;WANG Li-jing;HUANG Yong-cun(Mudanjiang Medical College, Mudanjiang, Heilongjiang Province, 157000 China;Mudanjiang Medical College, Mudanjiang, Heilongjiang Province, 157000 China)
出处 《世界复合医学》 2019年第6期154-156,共3页 World Journal of Complex Medicine
基金 黑龙江省大学生创新创业训练计划项目(201710229007)
关键词 同型半胱氨酸 超敏C反应蛋白 下肢深静脉血栓 诊断 Homocysteine Hypersensitive C-reactive protein Deep venous thrombosis of lower extremity Diagnosis
  • 相关文献

参考文献8

二级参考文献65

  • 1中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志(电子版),2010,2(4):50-59. 被引量:1842
  • 2祁瑞芳.老年脑梗死患者高同型半胱氨酸血症、氧化应激及炎性反应的相关性[J].中国老年学杂志,2014,34(8):2070-2071. 被引量:40
  • 3胡大一,许玉韵主编.循证心血管病学.第1版.天津:天津科学技术出版社.2001.581.
  • 4Engbers MJ, van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost, 2010,8:2105-2112.
  • 5Boeer K, Siegmund R, Schmidt D, et al. Comparison of six D-dimer assays for the detection of clinically suspected deep venous thrombosis of the low- er extremities. Blood Coagul Fibrinolysis,2009,20 : 141-145.
  • 6Bates SM, Jaeschke R, Stevens SM, et al. Diagnosis of DVT: Antithrombot- ic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012,141 :e351S-418S.
  • 7Jimnez D,Aujesky D, Diaz G, et al. Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary em- bolism. Am J Respir Crit Care Med,2010,181:983-991.
  • 8He L, Zeng H, Li F, et al. Homocysteine impairs coronary artery endotheli- al function by inhibiting tetrahydrobiopterin in patients with hyperhomocys- teinemia. Am J Physiol Endocrinol Metab ,2010,299 : E106!-1065.
  • 9Stangl V, Gunther C ,Jarrin A, et al. Homocysteine inhibits TNF alpha in- duced endothelial adhesion molecule expression and monocyte adhesion via nulear factor - Kappa B dependent pathway. Biochem Biophy Res Com- mun ,2001,280 : 1093.
  • 10Onishi T, Shimada K, Sunayama S, et al. Effects of cardiac rehabilitation in patients with metabolic syndrome after coronary artery bypass grafting. J Cardio1,2009,53:381-387.

共引文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部